(Q42662118)

4 November 2017

0 references

Biomarkers and personalized therapy in chronic kidney diseases (English)

1 reference

4 November 2017

0 references

Francesco Paolo Schena

series ordinal

1

1 reference

4 November 2017

language of work or name

English

0 references

publication date

26 May 2014

1 reference

Expert Opinion on Investigational Drugs

4 November 2017

published in

1 reference

4 November 2017

volume

23

1 reference

4 November 2017

issue

8

1 reference

4 November 2017

page(s)

1051-1054

1 reference

New therapeutic strategies under development to halt the progression of renal failure

4 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2014.922953

Personalized network-based treatments in oncology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2014.922953

Clinical use of novel biomarkers in heart failure: towards personalized medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2014.922953

From -omics to personalized medicine in nephrology: integration is the key.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2014.922953

Toward personalized medicine in renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2014.922953

Cardiac hypertrophy and remodeling in relation to ACE and angiotensinogen genes genotypes in Chinese dialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2014.922953

Cytochrome P450 pharmacogenetics as a predictor of toxicity and clinical response to pulse cyclophosphamide in lupus nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2014.922953

Pharmacogenetics in solid organ transplantation: current status and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2014.922953

The impact of uridine diphosphate-glucuronosyltransferase 1A9 (UGT1A9) gene promoter region single-nucleotide polymorphisms T-275A and C-2152T on early mycophenolic acid dose-interval exposure in de novo renal allograft recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2014.922953

Mitochondrial dysregulation and oxidative stress in patients with chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2014.922953

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2014.922953

Genome-wide association study for renal traits in the Framingham Heart and Atherosclerosis Risk in Communities Studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2014.922953

Biomarkers of kidney injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2014.922953

Role of mesenchymal stem cell-derived microvesicles in tissue repair.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2014.922953

Human renal stem/progenitor cells repair tubular epithelial cell injury through TLR2-driven inhibin-A and microvesicle-shuttled decorin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2014.922953

Altered modulation of WNT-beta-catenin and PI3K/Akt pathways in IgA nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2014.922953

Activated innate immunity and the involvement of CX3CR1-fractalkine in promoting hematuria in patients with IgA nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2014.922953

The anti-fibrotic effect of mycophenolic acid-induced neutral endopeptidase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2014.922953

CKD273, a new proteomics classifier assessing CKD and its prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2014.922953

Metabolites associate with kidney function decline and incident chronic kidney disease in the general population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2014.922953

Stratified medicine: strategic and economic implications of combining drugs and clinical biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2014.922953

Variability in the biological response to anti-CD20 B cell depletion in systemic lupus erythaematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2014.922953

10.1517/13543784.2014.922953

21 January 2018

Identifiers

DOI

1 reference

4 November 2017

1 reference